Slingshot members are tracking this event:
Allergan Announces U.S. Availability of VRAYLAR (cariprazine) for Treatment of Bipolar Mania and Schizophrenia in Adults
Do you think this event is important to the companies below? How will it affect their stock price?
|Impact on Stocks
Slingshot Insights Explained
Mar 16, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Vraylar, Cariprazine, Bipolar Mania, Schizophrenia